Skip to content
DraconiticResearch
Search Sources API
186,625 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY 4.0PLOS One

The incidence rates and prevalence of treated glaucoma in the United Kingdom, 2000–2022

  • Luis Velez-Nandayapa1
  • Laura Eggenschwiler2
  • Susan S. Jick3
  • Christoph R. Meier4
  • Claudia Becker5
5 affiliations
  1. 1Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
  2. 2Hospital Pharmacy, University Hospital Basel, Basel, Switzerland
  3. 3Augenpraxis Kuessnacht, Kuessnacht, Switzerland
  4. 4Boston University School of Public Health, Boston, Massachusetts, United States of America
  5. 5Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, United States of America
Open at sourcePDFDOICite

Abstract

Purpose: Quantify the incidence rates and prevalence of treated glaucoma in the United Kingdom (UK). Methods: Using data from the Clinical Practice Research Datalink (CPRD) GOLD, we calculated crude and age-standardised incidence rates and prevalence of treated glaucoma in adult patients from 2000 to 2022, stratifying by age, sex, year of diagnosis, and region. Results: We identified 112,632 cases of glaucoma in 82.7 million person-years (py) from 2000 to 2022. Conclusions: In our large nationwide study in the UK, the incidence rates of glaucoma in the UK remained fairly stable from 2000 to 2019, with a significant decrease observed in 2020 due to the COVID-19 pandemic. Meanwhile, the prevalence of glaucoma has increased, reflecting the aging population. Both the incidence rates and prevalence varied widely across age groups, sexes, and different regions of the UK. Considering the aging UK population and the increasing prevalence of glaucoma, this eye condition represents a growing burden on the National Health Service in the UK.

Related

  1. Social contact patterns in the United Kingdom following the COVID-19 pandemic: The Reconnect cross-sectional survey
    Lucy Goodfellow, Billy J. Quilty, Kevin van Zandvoort +1
    PLoS MedicinePeer-reviewedCC BY6 citedGeneral mathematicsOpenAlex
  2. Incidence and prevalence of acquired brain injury in children and young people globally: A systematic review and meta-analysis protocol
    Sophie Orchard, Kate Radford, Joseph C. Manning +2
    PLOS OnePeer-reviewedCC BY 4.0Full textStatisticsEpidemiology & public healthPLOS
  3. Shrinkage invalidates the Hosmer-Lemeshow test: goodness of fit for penalized logistic regression, with an application to glaucoma diagnosis
    Ebrahim Khaled Ebrahim
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  4. Derivations of the idealization of the incidence module over the finitary incidence algebra
    Érica Zancanella Fornaroli, Roger Emanuel Moraes Pezzott
    arXivPreprintarXiv licenceFull textAlgebra & number theoryarXiv
  5. An incidence approach to cross-intersection in semilattices
    Sho Suda
    arXivPreprintCC BY 4.0Full textCombinatorics & discrete mathematicsarXiv

Cite

BibTeXRIS
BibTeX
@article{veleznandayapa2026incidence,
  title = {{The incidence rates and prevalence of treated glaucoma in the United Kingdom, 2000–2022}},
  author = {Luis Velez-Nandayapa and Laura Eggenschwiler and Susan S. Jick and Christoph R. Meier and Claudia Becker},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0354463},
  url = {https://doi.org/10.1371/journal.pone.0354463},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The incidence rates and prevalence of treated glaucoma in the United Kingdom, 2000–2022
AU  - Luis Velez-Nandayapa
AU  - Laura Eggenschwiler
AU  - Susan S. Jick
AU  - Christoph R. Meier
AU  - Claudia Becker
PY  - 2026
DA  - 2026/09/03
JO  - PLOS One
DO  - 10.1371/journal.pone.0354463
UR  - https://doi.org/10.1371/journal.pone.0354463
AB  - Purpose: Quantify the incidence rates and prevalence of treated glaucoma in the United Kingdom (UK). Methods: Using data from the Clinical Practice Research Datalink (CPRD) GOLD, we calculated crude and age-standardised incidence rates and prevalence of treated glaucoma in adult patients from 2000 to 2022, stratifying by age, sex, year of diagnosis, and region. Results: We identified 112,632 cases of glaucoma in 82.7 million person-years (py) from 2000 to 2022. Conclusions: In our large nationwide study in the UK, the incidence rates of glaucoma in the UK remained fairly stable from 2000 to 2019, with a significant decrease observed in 2020 due to the COVID-19 pandemic. Meanwhile, the prevalence of glaucoma has increased, reflecting the aging population. Both the incidence rates and prevalence varied widely across age groups, sexes, and different regions of the UK. Considering the aging UK population and the increasing prevalence of glaucoma, this eye condition represents a growing burden on the National Health Service in the UK.
SN  - 1932-6203
ER  -